How have ENLV and NVNO total returns compared?

Over the past 5 years, ENLV delivered -69.81% and NVNO delivered -52.99% annualized total return. Past performance doesn't predict future results.

Enlivex Therapeutics Ltd. (ENLV) vs enVVeno Medical Corporation (NVNO)

A side-by-side comparison of Enlivex Therapeutics Ltd. and enVVeno Medical Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ENLV

Enlivex Therapeutics Ltd.

$6M

$0.36HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT

NVNO

enVVeno Medical Corporation

$6M

$8.58HealthcareDelayed quote: Oct 6, 2026, 11:33 AM EDT

Total return — ENLV vs NVNO

growth of $100 · dividends reinvested · last 8y

ENLV -99.9% (-56.3%/yr)NVNO -99.8% (-54.9%/yr)NVNO compounded faster over this window

ENLV NVNO

ENLV vs NVNO: by the numbers

•ENLV is the larger company ($6M vs $6M market cap).

Metrics side by side

Valuation

Metric	ENLV	NVNO
P/E ratio	0.00	N/A
P/B ratio	0.00	0.29

Profitability

Metric	ENLV	NVNO
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	0.00%
ROE	105.35%	-76.07%
ROIC	-0.32%	-80.65%

Growth (annualized)

Metric	ENLV	NVNO
Total return CAGR (5Y)	-69.81%	-52.99%

Frequently asked

How have ENLV and NVNO total returns compared?: Over the past 5 years, ENLV delivered -69.81% and NVNO delivered -52.99% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ENLV analysis Full NVNO analysis Interactive comparison tool

Dig into the metrics

Enlivex Therapeutics ROE enVVeno Medical ROE Enlivex Therapeutics operating margin enVVeno Medical operating margin Enlivex Therapeutics revenue growth enVVeno Medical revenue growth Enlivex Therapeutics free cash flow enVVeno Medical free cash flow

Enlivex Therapeutics & enVVeno Medical appear in these rankings

Highest ROE Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.